Pliant Therapeutics (PLRX) Stock Price
$1.46 0%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
1 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Pliant Therapeutics, AI stock picks, stock alerts and much more.
PLRX AI Stock Analysis
AI stock analysis for PLRX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Pliant Therapeutics (PLRX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Pliant Therapeutics (PLRX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Pliant Therapeutics (PLRX), currently trading at $1.46, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About PLRX
-
Pliant Therapeutics, Inc.
-
Symbol
PLRX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
89.6M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$22.52 1.5% |
5 |
 |
Inovio Pharmaceuticals INO |
$1.74 1.2% |
1 |
 |
Moderna MRNA |
$24.72 1.9% |
3 |
 |
Anavex Life Sciences AVXL |
$8.95 1.2% |
5 |
 |
BridgeBio Pharma BBIO |
$33.87 0.1% |
4 |
News
PLRX Alternative Data
Web Traffic
Pliant Therapeutics receives an estimated 13352 monthly visitors to pliantrx.com.
-
Web Traffic
13352
-
Change from Previous Month
36.3%
-
3 Month Change
91%
-
YoY Change
91%
News Mentions
Pliant Therapeutics was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Pliant Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
Twitter Followers
Pliant Therapeutics has 483 Twitter Followers on its main Twitter (also known as X) account, which is down by -1.2% over the last month.
-
Twitter Followers
483
-
Daily Change
0%
-
1 Month Change
1.2%
-
3 Month Change
5.2%
-
YoY Change
5.2%
Facebook Engagement
Pliant Therapeutics has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
100%
-
YoY Change
100%
Youtube Subscribers
Pliant Therapeutics has 114 subscribers on its main Youtube channel, up by 3.6% over the last month.
-
Youtube Subscribers
114
-
Daily Change
0%
-
1 Month Change
3.6%
-
3 Month Change
11.8%
-
YoY Change
11.8%
Job Postings
Pliant Therapeutics has an estimated 0 open job postings, which is down -100% over the last month.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
100%
-
YoY Change
100%
LinkedIn Followers
12,918 are following Pliant Therapeutics on LinkedIn, up by 1.5% over the last month.
-
LinkedIn Followers
12918
-
Daily Change
0%
-
1 Month Change
1.5%
-
3 Month Change
4.5%
LinkedIn Employees
According to LinkedIn, Pliant Therapeutics has 180 employees.
-
LinkedIn Employees
180
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
3.7%
-
YoY Change
3.7%
Business Outlook
According to employee reviews, the business outlook among employees at Pliant Therapeutics is 100 out of 100 (very bullish).
-
Business Outlook
100
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
PLRX Financials
PLRX Key Metrics
-
Total Revenue
$0
-
Net Income
-$49.7M
-
Earnings per Share
-$3.47
-
Free cash flow
-$47.9M
-
EBITDA
-$48.4M
-
EBITDA Ratio
0
-
Total Assets
$396.9M
PLRX 2-year Revenue & Income
PLRX 2-year Free Cash Flow
PLRX Technicals
PLRX SMA
PLRX RSI
FAQ
What's the current price of Pliant Therapeutics (PLRX) Stock?
The price of an Pliant Therapeutics (PLRX) share is $1.46.
What's the market cap of Pliant Therapeutics?
The current market cap of Pliant Therapeutics is 89.6M.
Should I buy or sell PLRX?
Pliant Therapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Pliant Therapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is Pliant Therapeutics a good investment?
The current analysis of Pliant Therapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Pliant Therapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Pliant Therapeutics (PLRX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Pliant Therapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Pliant Therapeutics (PLRX) that investors often compare it to?
Pliant Therapeutics (PLRX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Pliant Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Pliant Therapeutics' stock price to be around $1.45 in 2026. Starting from the current price of $1.46, this represents a 0.5% change in price, indicating a neutral outlook for the stock.
How to buy Pliant Therapeutics (PLRX) Stock?
Pliant Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Pliant Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.